Hongjun Li

8.4k total citations · 8 hit papers
153 papers, 6.8k citations indexed

About

Hongjun Li is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hongjun Li has authored 153 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 36 papers in Oncology and 33 papers in Immunology. Recurrent topics in Hongjun Li's work include Nanoplatforms for cancer theranostics (20 papers), Nanoparticle-Based Drug Delivery (20 papers) and CAR-T cell therapy research (17 papers). Hongjun Li is often cited by papers focused on Nanoplatforms for cancer theranostics (20 papers), Nanoparticle-Based Drug Delivery (20 papers) and CAR-T cell therapy research (17 papers). Hongjun Li collaborates with scholars based in China, United States and Singapore. Hongjun Li's co-authors include Jun Wang, Zhen Gu, Jin‐Zhi Du, Xiao‐Jiao Du, Xianzhu Yang, Cong‐Fei Xu, Song Shen, Shuming Nie, Di Wen and Guojun Chen and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Hongjun Li

146 papers receiving 6.8k citations

Hit Papers

Stimuli-responsive clustered nanoparticles for improved t... 2016 2026 2019 2022 2016 2016 2021 2021 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongjun Li China 42 3.2k 2.5k 2.1k 1.1k 905 153 6.8k
Margaret M. Billingsley United States 26 2.7k 0.8× 3.9k 1.5× 2.2k 1.0× 1.2k 1.1× 992 1.1× 37 7.9k
Xudong Zhang China 32 3.5k 1.1× 2.1k 0.8× 1.7k 0.8× 1.8k 1.6× 1.2k 1.3× 63 6.4k
Aliasger K. Salem United States 49 3.0k 0.9× 2.8k 1.1× 1.7k 0.8× 1.3k 1.2× 630 0.7× 230 8.0k
Betty Tyler United States 51 2.6k 0.8× 2.5k 1.0× 2.5k 1.2× 932 0.8× 1.4k 1.6× 206 8.7k
Yinlong Zhang China 46 4.1k 1.3× 4.0k 1.6× 2.6k 1.2× 1.4k 1.2× 1.2k 1.4× 93 8.4k
Zhiping Zhang China 48 2.9k 0.9× 4.2k 1.7× 3.2k 1.5× 1.1k 1.0× 1.0k 1.2× 168 9.7k
Xiao Zhao China 43 3.1k 1.0× 2.8k 1.1× 1.5k 0.7× 1.7k 1.5× 1.0k 1.1× 89 6.4k
Jian You China 52 3.8k 1.2× 2.7k 1.1× 2.6k 1.2× 1.2k 1.0× 665 0.7× 164 7.8k
Jun Cao China 41 2.6k 0.8× 2.0k 0.8× 2.2k 1.0× 657 0.6× 751 0.8× 190 6.3k
Shyh‐Dar Li Canada 38 2.8k 0.9× 3.3k 1.3× 3.5k 1.7× 549 0.5× 641 0.7× 92 7.0k

Countries citing papers authored by Hongjun Li

Since Specialization
Citations

This map shows the geographic impact of Hongjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjun Li more than expected).

Fields of papers citing papers by Hongjun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjun Li. The network helps show where Hongjun Li may publish in the future.

Co-authorship network of co-authors of Hongjun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hongjun Li. A scholar is included among the top collaborators of Hongjun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongjun Li. Hongjun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Peng, Wei Hui, Guosheng Fu, et al.. (2025). Biomimetic peroxisome targets myocardial injury and promotes heart repair and regeneration. Biomaterials. 319. 123214–123214. 2 indexed citations
2.
Wen, Ping, Hanwei Huang, Ruizhe Zhang, et al.. (2025). Coacervate vesicles assembled by liquid–liquid phase separation improve delivery of biopharmaceuticals. Nature Chemistry. 17(2). 279–288. 31 indexed citations breakdown →
3.
Wang, Yutao, Xun Fu, & Hongjun Li. (2025). Mechanisms of oxidative stress-induced sperm dysfunction. Frontiers in Endocrinology. 16. 1520835–1520835. 39 indexed citations breakdown →
4.
Fu, Xun, et al.. (2024). Association between metabolic syndrome and benign prostatic hyperplasia: The underlying molecular connection. Life Sciences. 358. 123192–123192. 13 indexed citations
5.
Zhou, Ruyi, Hao Yu, Tao Sheng, et al.. (2024). Grooved Microneedle Patch Augments Adoptive T Cell Therapy Against Solid Tumors via Diverting Regulatory T Cells. Advanced Materials. 36(30). e2401667–e2401667. 18 indexed citations
6.
Jiang, Jie, Wei Wu, Jiaqi Shi, et al.. (2024). Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor. National Science Review. 11(4). nwae018–nwae018. 24 indexed citations
7.
You, Jiahuan, Jinpeng Han, Hao Wang, et al.. (2023). Ultrarapid‐Acting Microneedles for Immediate Delivery of Biotherapeutics. Advanced Materials. 35(45). e2304582–e2304582. 46 indexed citations
8.
Huang, Hanwei, Mengchi Sun, Ruizhe Zhang, et al.. (2023). Inhibition of Tumor Metastasis by Liquid‐Nitrogen‐Shocked Tumor Cells with Oncolytic Viruses Infection. Advanced Materials. 35(28). e2212210–e2212210. 36 indexed citations
9.
Shen, Xinyuan, Chaojie Zhu, Xutao Liu, et al.. (2023). Engineered bacteria for augmentedin situtumor vaccination. Biomaterials Science. 11(4). 1137–1152. 21 indexed citations
10.
Ma, Yinchu, Ying‐Li Luo, Xinfeng Tang, et al.. (2023). Ferric iron coordinated cisplatin prodrug reprograms the immune-cold tumor microenvironment through tumor hypoxia relief for enhanced cancer photodynamic-immunotherapy. Nano Research. 16(7). 9930–9939. 4 indexed citations
11.
Chen, Xiaohong, Shuang Wang, Yuxuan Chen, et al.. (2023). Non-invasive activation of intratumoural gene editing for improved adoptive T-cell therapy in solid tumours. Nature Nanotechnology. 18(8). 933–944. 62 indexed citations
12.
Ren, En, Yanfang Wang, Tingxizi Liang, et al.. (2023). Local Drug Delivery Techniques for Triggering Immunogenic Cell Death. Small Methods. 7(9). e2300347–e2300347. 14 indexed citations
13.
Huang, Hanwei, Mengchi Sun, Ruizhe Zhang, et al.. (2023). Inhibition of Tumor Metastasis by Liquid‐Nitrogen‐Shocked Tumor Cells with Oncolytic Viruses Infection (Adv. Mater. 28/2023). Advanced Materials. 35(28). 9 indexed citations
14.
Lou, Xinyu, Jinqiang Wang, Xu Wang, et al.. (2023). An oral bacterial pyroptosis amplifier against malignant colon cancer. Nano Today. 54. 102091–102091. 13 indexed citations
15.
Zhang, Ning, Mengkang Fan, Yongchao Zhao, et al.. (2023). Biomimetic and NOS‐Responsive Nanomotor Deeply Delivery a Combination of MSC‐EV and Mitochondrial ROS Scavenger and Promote Heart Repair and Regeneration. Advanced Science. 10(21). e2301440–e2301440. 37 indexed citations
16.
Wang, Chao, Lili Yang, Juan Du, et al.. (2022). Dynamics of influenza‐like illness under urbanization procedure and COVID‐19 pandemic in the subcenter of Beijing during 2013–2021. Journal of Medical Virology. 94(8). 3801–3810. 9 indexed citations
17.
Liu, Lu, Hongjun Li, Jinqiang Wang, et al.. (2022). Leveraging macrophages for cancer theranostics. Advanced Drug Delivery Reviews. 183. 114136–114136. 45 indexed citations
18.
Li, Hongjun, Zejun Wang, Zhaowei Chen, et al.. (2021). Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis. Nature Communications. 12(1). 2773–2773. 62 indexed citations
19.
Wang, Zejun, Jinqiang Wang, Hongjun Li, et al.. (2020). Dual self-regulated delivery of insulin and glucagon by a hybrid patch. Proceedings of the National Academy of Sciences. 117(47). 29512–29517. 95 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026